Perbedaan Organon Pharma Indonesia Tbk. dan Urban Jakarta Propertindo Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Urban Jakarta Propertindo Tbk. diperdagangkan di Rp218 (kapitalisasi pasar 717,53 M, volume 24 jam 90,4 rb). Perbedaan utamanya: Urban Jakarta Propertindo Tbk. jauh lebih besar — sekitar 6,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | URBN | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 717,53 M |
Volume | — | 90,4 rb |
Lot | — | 904 |
Perputaran | — | 19,97 jt |
Harga Rata-rata | — | 220,94 |
Nilai Transaksi | — | 19,97 jt |
Harga Ekuilibrium Indikatif | — | 218 |
Volume Ekuilibrium Indikatif | — | 240 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Urban Jakarta Propetindo (Company) was established in Jakarta under the framework of ForeignCapital Investment Law No. 1 year 1967 of the Republic of Indonesia as amended and revised by Law No. 11 year 1970, based on the notarial deed No. 62, dated May 9, 1995, of Sinta Susikto, S.H., has been amended several times by notarial deen No. 138 dated October 25, 1995 of the same notary.
Selengkapnya di halaman URBN →